6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine manufacturers
|
| | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine Basic information |
| Product Name: | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine | | Synonyms: | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine;2’-β-C-Methyl-2’,3’,5’-tri-O-acetyl-β-D-6-methylpurine riboside;9-(2',3',5'-Tri-O-benzoyl-2'-C-methyl-b-D-ribofuranosyl)6-methylpurine;2’-β-C-Methyl-2’,3’,5’-tri-O-benzoyl-β-D-6-methylpurine riboside;6-Methyl-9-(2-C-methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine, 2’-C-Methyl-2’,3’,5’-tri-O-acetyl-beta-D-6-methylpurine riboside;(2R,3R,4R,5R)-5-((benzoyloxy)methyl)-3-methyl-2-(6-methyl-9H-purin-9-yl)tetrahydrofuran-3,4-diyldibenzoate | | CAS: | 2095417-61-9 | | MF: | C33H28N4O7 | | MW: | 592.61 | | EINECS: | | | Product Categories: | | | Mol File: | 2095417-61-9.mol |  |
| | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine Chemical Properties |
| Boiling point | 746.9±70.0 °C(Predicted) | | density | 1.35±0.1 g/cm3(Predicted) | | pka | 3.50±0.10(Predicted) |
| | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine Usage And Synthesis |
| Uses | 6-Methyl-9-(2-β-C-methyl-2,3,5-tri-O-benzoyl-β-D-ribofuranosyl)purine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | | References | [1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
| | 6-Methyl-9-(2-C-Methyl-2,3,5-tri-O-benzoyl-beta-D-ribofuranosyl)purine Preparation Products And Raw materials |
|